Kevin Chung
Company: SeaStar Medical
Job title: Chief Medical Officer
Seminars:
The Selective Cytopheretic Device: A Novel Cell-directed Extracorporeal Therapy Targeting the Host-Response 9:30 am
Despite improvements in critical care medicine, acute kidney injury continues to cause high mortality rates in critically ill patients. AKI promotes a systemic inflammatory response resulting in microvascular damage and can lead to multi-organ dysfunction. This session will describe the processes of a dysregulated immune response, the mechanism of action of the novel selective cytopheretic…Read more
day: Conference Day 2